Compare DLX & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DLX | AORT |
|---|---|---|
| Founded | 1915 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 975.7M |
| IPO Year | 1994 | 1996 |
| Metric | DLX | AORT |
|---|---|---|
| Price | $23.48 | $22.59 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $23.00 | ★ $49.40 |
| AVG Volume (30 Days) | 404.8K | ★ 737.7K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.99% | N/A |
| EPS Growth | 52.54 | ★ 165.62 |
| EPS | ★ 0.77 | 0.03 |
| Revenue | ★ $2,133,200,000.00 | $298,836,000.00 |
| Revenue This Year | $1.35 | $14.20 |
| Revenue Next Year | $1.30 | $11.20 |
| P/E Ratio | ★ $30.52 | $734.33 |
| Revenue Growth | 0.54 | ★ 18.01 |
| 52 Week Low | $15.41 | $19.16 |
| 52 Week High | $32.07 | $48.25 |
| Indicator | DLX | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 46.88 | 51.28 |
| Support Level | $22.10 | $21.76 |
| Resistance Level | $24.70 | $24.70 |
| Average True Range (ATR) | 0.82 | 0.99 |
| MACD | 0.17 | 0.63 |
| Stochastic Oscillator | 66.03 | 99.04 |
Deluxe Corp is principally a payments and data company. Its reportable segments are: Merchant Services, B2B Payments, Data Solutions, and Print. Maximum revenue is derived from its Print segment, which provides printed personal and business checks, business essentials, as well as branded promotional, print, apparel, and digital storefront solutions. The Merchant Services segment provides electronic credit and debit card authorization, payment systems, and processing services. The B2B segment offers treasury management solutions, integrated accounts payable disbursements, and fraud and security services, and the Data Solutions segment offers data, analytics, and marketing services, as well as financial institution profitability reporting and business incorporation services.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.